Lataa...

Is there a role for [(18)F]-FMISO PET to guide dose adaptive radiotherapy in head and neck cancer? A review of the literature

PURPOSE: Hypoxia is a major cause of radioresistance in head and neck cancer (HNC), resulting in treatment failure and disease recurrence. (18)F-fluoromisonidazole [(18)F]FMISO PET has been proposed as a means of localising intratumoural hypoxia in HNC so that radiotherapy can be specifically escala...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Transl Imaging
Päätekijät: Sambasivan, Khrishanthne, Barrington, Sally F, Connor, Steve EJ, Witney, Timothy H, Blower, Philip J, Urbano, Teresa Guerrero
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2024
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616449/
https://ncbi.nlm.nih.gov/pubmed/39286295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40336-023-00607-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!